![](https://news.europawire.eu/wp-content/uploads/2022/11/AstraZenecas-RD-Postdoctoral-Challenge-144x144.jpg)
(PRESS RELEASE) CAMBRIDGE, 2-Nov-2022 — /EuropaWire/ — AstraZeneca (LSE/STO/Nasdaq: AZN), a British-Swedish multinational pharmaceutical and biotechnology company, has announced fully funded postdoctoral research positions for the six winners at its R&D Postdoctoral Challenge announced earlier this year. The research positions … Read the full press release